In 2024, startups saw a notable resurgence in large-scale funding rounds. By May, over 100 startups had secured funding ...

BEAM appoints Sravan K. Emany as its new chief financial officer, effective Dec. 19. Shares rise on this leadership transition.

It develops BEAM-101 for the treatment of sickle cell disease or beta-thalassemia; and BEAM-302, a liver-targeting LNP ...

Mereo Biopharma Group Plc (MREO) has received a new Buy rating, initiated by Jefferies analyst, Maury Raycroft.Don't Miss our Black Friday ...

A month has gone by since the last earnings report for Krystal Biotech, Inc. (KRYS). Shares have added about 6.6% in that time frame, outperforming the S&P 500. Will the recent positive trend continue ...

Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder associated with liver disease, ranging from fibrosis to ...

AVG-002 is being developed by AlveoGene using its InGenuiTy® platform, which employs a unique pseudotyped lentiviral vector to deliver a functional SP-B gene directly to the neonaal deep lung alveolar ...

R.W. Johnson shares the harrowing journey of supporting his younger sister, Helen, in her decision to seek assisted dying in Zurich.

Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) has received an average recommendation of “Moderate Buy” from the twelve brokerages that are covering the stock, Marketbeat Ratings reports. Four ...

The most effective treatment for COPD is smoking cessation which is important as over six million people in the UK continue to smoke. This month the NHS has rolled out a ‘stop-smoking’ pill called ...

Penny stocks are shares of smaller or newer companies, often in their early stages of development. These companies, however, ...

CRISPR gene editing based treatment reduced HAE attacks rates by up to 80%. NTLA-2002 was well tolerated by patients. The ...